We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA to Exempt Phase I Drugs From GMP Requirements
FDA to Exempt Phase I Drugs From GMP Requirements
July 23, 2008
After withdrawing a final rule more than two years ago to exempt investigational drugs in Phase I testing from certain good manufacturing practice (GMP) regulations, the FDA is issuing another final rule that will do just that.